Multiple sclerosis
disease that damages the myelin sheaths around nerve axons
Multiple sclerosis (MS) is a chronic and neurodegenerative autoimmune disease in which the immune system attacks myelin, the insulating cover of nerve cells, causing damage to the central nervous system. This impairs the nervous system's ability to transmit signals. Symptoms include double vision, vision loss, eye pain, muscle weakness, loss of coordination, as well as cognitive issues like problems with memory.
MS may be a rare complication of an Epstein-Barr virus (EBV) infection. Genetics and environmental factors like exposure to sunlight also impact the risk of MS. MS can be diagnosed based on symptoms, MRI scans, and sometimes a lumbar puncture to investigate spinal fluid.
There is no cure for MS. Current treatments aim to manage symptoms during acute flares and prevent further attacks with disease-modifying therapies. With effective treatment, it is possible to reduce attacks strongly, but the disease progress is not fully stopped. In addition, symptoms of MS like balance issues can be managed with drugs and with non-drug treatments (e.g. physical therapy). On average, life expectancy is slightly lower than normal.
Begin with the source’s own compact description: “Multiple sclerosis” is disease that damages the myelin sheaths around nerve axons. The dossier treats that line as a proposition to test through Multiple, sclerosis and disease, not as a finished interpretation.
Why this record matters
The phrase “disease that damages the myelin sheaths around nerve axons” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 22, 2026. The linked authority identifier is Q8277. The Library of Congress control number is sh85088374. 1 of 1 selected statements include explicit references; 1 carry qualifiers and 0 use preferred rank.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Multiple sclerosis”, its source revision and the description used here.
- Expand the search: follow Multiple sclerosis primary sources, Multiple sclerosis archive and Multiple research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Multiple sclerosis”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Multiple sclerosis” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.